Literature DB >> 10583170

Clinical measurement of dimensions of basal cell carcinoma: effect of waiting for elective surgery.

M E Kirkup1, D A De Berker.   

Abstract

Fifty well-defined basal cell carcinomas (BCCs) on the face, outside the central T, were studied to establish change in size between initial assessment and surgery. The major and minor diameters were measured at presentation and when the patients attended for elective excision 21-155 days later (mean 70). The median change in major diameter was an increase of 0.5 mm (range - 3 to + 4, P < 0.05). The median change in area was 4.71 mm2 (range - 54 to + 64, P < 0.05). Although there is a statistically significant increase in major diameter and area, it was small in clinical terms. The major axis increased by > 1 mm in 8% of cases. In no case was treatment or completeness of excision compromised by waiting. A mean delay of 10 weeks between review and surgery does not appear to compromise the outcome of treatment of BCC in patients with well-defined BCCs of the face outside the central T.

Entities:  

Mesh:

Year:  1999        PMID: 10583170     DOI: 10.1046/j.1365-2133.1999.03111.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  Relationship of treatment delay with surgical defect size from keratinocyte carcinoma (basal cell carcinoma and squamous cell carcinoma of the skin).

Authors:  Melody J Eide; Martin A Weinstock; Raymond G Dufresne; Suleka Neelagaru; Patricia Risica; Gary J Burkholder; David Upegui; Katharine A Phillips; Bruce K Armstrong; Leslie Robinson-Bostom
Journal:  J Invest Dermatol       Date:  2005-02       Impact factor: 8.551

2.  Correlation Between Demographic and Tumor Characteristics in Non-melanoma Skin Cancers Submitted to Mohs Micrographic Surgery.

Authors:  Ellem T S Weimann; Caroline M BrandÃo; Luiz R Terzian; Francisco M Paschoal; Carlos D S Machado Filho; Paulo R Criado
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

3.  The facial skin lesions "see and treat" clinic: A prospective study.

Authors:  Mahmoud A Salam; Vandana Matai; Mohamed Salhab; A W Hilger
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-05-13       Impact factor: 2.503

4.  Initial basal cell carcinomas diagnosed in the National Campaign for Skin Cancer Prevention are smaller than those identified by the conventional medical referral system.

Authors:  Thweicyka Pinheiro Wakiyama; Maria Laura Marconi França; Larissa Pierri Carvalho; Mariangela Esther Alencar Marques; Hélio Amante Miot; Juliano Vilaverde Schmitt
Journal:  An Bras Dermatol       Date:  2017 Jan-Feb       Impact factor: 1.896

Review 5.  Management of primary skin cancer during a pandemic: Multidisciplinary recommendations.

Authors:  Brian C Baumann; Kelly M MacArthur; Jerry D Brewer; William M Mendenhall; Christopher A Barker; Jeremy R Etzkorn; Nathaniel J Jellinek; Jeffrey F Scott; Hiram A Gay; John C Baumann; Farrin A Manian; Phillip M Devlin; Jeff M Michalski; Nancy Y Lee; Wade L Thorstad; Lynn D Wilson; Carlos A Perez; Christopher J Miller
Journal:  Cancer       Date:  2020-06-01       Impact factor: 6.860

6.  Factors influencing current low-value follow-up care after basal cell carcinoma and suggested strategies for de-adoption: a qualitative study.

Authors:  S van Egmond; M Wakkee; A van Rengen; M T Bastiaens; T Nijsten; M Lugtenberg
Journal:  Br J Dermatol       Date:  2019-03-28       Impact factor: 9.302

Review 7.  Head and neck cutaneous basal cell carcinoma: what should the otorhinolaryngology head and neck surgeon care about?

Authors:  António Castanheira; Paula Boaventura; Manuel Pais Clemente; Paula Soares; Alberto Mota; José Manuel Lopes
Journal:  Acta Otorhinolaryngol Ital       Date:  2019-07-31       Impact factor: 2.124

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.